文献速递临床试验与 GCP

基于正念的干预(M-Body)对抑郁症状的比较效果:联邦合格健康中心随机对照试验研究方案

Comparative effectiveness of a mindfulness-based intervention (M-Body) on depressive symptoms: study protocol of a randomized controlled trial in a Federally Qualified Health Center (FQHC).
PubMed 文献 · Trials · 2023-02-17

本研究为2臂分层个体随机组治疗对照试验,计划纳入274名18-65岁有抑郁症状的英语参与者,随机分配至8次每周90分钟的正念干预(M-Body)组或强化常规照护组,主要结局为6个月后抑郁症状评分。若M-Body有效,可增加服务不足的少数族裔社区获得心理治疗的机会。

要点

  • 在联邦合格健康中心以 predominantly 黑人女性为对象评估M-Body对抑郁症状的效果与实施。
  • 274名有抑郁症状的18-65岁英语参与者随机接受M-Body或强化常规照护。
  • 主要结局为基线后6个月抑郁症状评分,并在基线及2、4、6个月评估。

核心结论

  • 若M-Body被发现有对抑郁症状成人有效,这一可及、可扩展的治疗将广泛增加服务不足的种族/族裔少数社区获得心理治疗的机会。

研究设计与样本

  • 2臂、分层、个体随机、组治疗对照试验,计划纳入274名18-65岁有抑郁症状的英语参与者。

主要发现

  • 研究方案尚未报告结局数据。

关键数值与推荐

  • 主要结局为基线后6个月抑郁症状评分。
  • 评估时间点为基线及基线后2、4、6个月。
  • 排除标准包括入组前30天内有自杀意念及规律冥想练习(>4次/周)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mindfulness-based interventions have been shown to improve psychological outcomes including stress, anxiety, and depression in general population studies. However, effectiveness has not been sufficiently examined in racially and ethnically diverse community-based settings. We will evaluate the effectiveness and implementation of a mindfulness-based intervention on depressive symptoms among predominantly Black women at a Federally Qualified Health Center in a metropolitan city. METHODS: In this 2-armed, stratified, individually randomized group-treated controlled trial, 274 English-speaking participants with depressive symptoms ages 18-65 years old will be randomly assigned to (1) eight weekly, 90-min group sessions of a mindfulness-based intervention (M-Body), or (2) enhanced usual care. Exclusion criteria include suicidal ideation in 30 days prior to enrollment and regular (>4x/week) meditation practice. Study metrics will be assessed at baseline and 2, 4, and 6 months after baseline, through clinical interviews, self-report surveys, and stress biomarker data including blood pressure, heart rate, and stress related biomarkers. The primary study outcome is depressive symptom score after 6 months. DISCUSSION: If M-Body is found to be an effective intervention for adults with depressive symptoms, this accessible, scalable treatment will widely increase access to mental health treatment in underserved, racial/ethnic minority communities. TRIAL REGISTRATION: ClinicalTrials.gov NCT03620721. Registered on 8 August 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Burnett-Zeigler I, Zhou E, Martinez JH, et al. Comparative effectiveness of a mindfulness-based intervention (M-Body) on depressive symptoms: study protocol of a randomized controlled trial in a Federally Qualified Health Center (FQHC). Trials. 2023. PMID: 36803835. doi:10.1186/s13063-022-07012-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。